CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-18 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +24,000 | 24,000 | ||
| 2024-04-18 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +24,000 | 24,000 | ||
| 2024-04-11 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | Sale | −257 | $22.49 | $6K | 22,891 |
| 2024-04-03 | Lee Kevin CHIEF EXECUTIVE OFFICER | Sale | −3,158 | $23.81 | $75K | 387,270 |
| 2024-04-03 | Skynner Michael CHIEF TECHNOLOGY OFFICER | Sale | −955 | $23.81 | $23K | 94,884 |
| 2024-04-03 | Milnes Alistair CHIEF OPERATING OFFICER | Sale | −955 | $23.81 | $23K | 72,241 |
| 2024-04-03 | Crockett Nigel CHIEF BUSINESS OFFICER | Sale | −955 | $23.81 | $23K | 47,761 |
| 2024-04-03 | Keen Nicholas CHIEF SCIENTIFIC OFFICER | Sale | −790 | $23.81 | $19K | 62,803 |
| 2024-04-03 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale | −152 | $23.81 | $4K | 23,223 |
| 2024-03-19 | Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF | Grant or award · Employee Stock Option (right to buy) | +58,000 | 58,000 | ||
| 2024-02-20 | Sands Stephen H. Director | Grant or award | +12,000 | 12,000 | ||
| 2024-02-20 | Sands Stephen H. Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2024-02-06 | Arroyo Santiago CHIEF DEVELOPMENT OFFICER | Grant or award | +21,660 | 39,000 | ||
| 2024-02-06 | Arroyo Santiago CHIEF DEVELOPMENT OFFICER | Grant or award · Employee Stock Option (right to buy) | +41,570 | 41,570 | ||
| 2024-01-03 | Thompson Travis Alvin Chief Accounting Officer | Sale | −604 | $17.50 | $11K | 23,375 |
| 2024-01-03 | Keen Nicholas Chief Scientific Officer | Sale | −2,640 | $17.50 | $46K | 63,593 |
| 2024-01-03 | Crockett Nigel Chief Business Officer | Sale | −2,643 | $17.50 | $46K | 48,716 |
| 2024-01-03 | Milnes Alistair Chief Operating Officer | Sale | −2,643 | $17.50 | $46K | 73,196 |
| 2024-01-03 | Skynner Michael Chief Technology Officer | Sale | −2,643 | $17.50 | $46K | 95,839 |
| 2024-01-03 | Lee Kevin Chief Executive Officer | Sale | −8,703 | $17.50 | $152K | 390,428 |
Page 12 of 26 · 520 trades